SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-21-003396
Filing Date
2021-11-04
Accepted
2021-11-04 16:12:02
Documents
2
Period of Report
2021-10-25

Document Format Files

Seq Description Document Type Size
1 zk2126756.html 3  
1 zk2126756.xml 3 3231
2 EXHIBIT 24.1 exhibit_24-1.htm EX-24.1 8053
  Complete submission text file 0001178913-21-003396.txt   12785
Mailing Address ACUITY PHARMACEUTICALS INC 3701 MARKET STREET PHILADELPHIA PA 19104
Business Address
Pfost Dale R (Reporting) CIK: 0001394663 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 211380065

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations